What is Edwards Lifesciences's D&A?

Edwards Lifesciences (EW) reported D&A of $40.9M in Q1 2026.

How has Edwards Lifesciences's D&A changed year-over-year?

Edwards Lifesciences's D&A increased by 11.7% year-over-year, from $36.6M to $40.9M.

What is the long-term trend for Edwards Lifesciences's D&A?

Over 4 years (2021 to 2025), Edwards Lifesciences's D&A has grown at a 3.8% compound annual growth rate (CAGR), from $134.8M to $156.6M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Edwards Lifesciences EW D&A

D&A at other companies

ArtivionAORT

$6.34M+16.4%

Merit Medical SystemsMMSI

$30.5M+4.1%

ICU MedicalICUI

$50.03M+1.2%

Boston ScientificBSX

$351M+8.0%

LeMaitre VascularLMAT

$2.62M+2.8%

MedtronicMDT

$716M-14.8%

Other financials

Income statement

See full

Revenue$1.6B+16.7%

Gross profit$1.3B+15.7%

Operating income$477.6M+21.0%

Net income$380.7M+6.3%

EPS (diluted)$0.66+8.2%

Balance sheet

See full

Cash & equivalents$2.4B-22.3%

Total debt$702.9M+0.5%

Total equity$10.3B+2.0%

Total assets$13.3B+2.3%

Cash flow

See full

Operating cash flow$43.8M-84.4%

CapEx$64.9M+15.9%

Free cash flow-$21.1M-109%

Valuation

See full

Market cap$52.09B+20.1%

Enterprise value$50.34B+23.3%

P/E47.5×+37.1×

P/S8.3×+0.6×

Profitability

See full

Gross margin77.9%-1.6pp

Operating margin21.4%-4.4pp

Net margin17.4%-58.3pp

FCF margin17.3%—

Returns & leverage

See full

Return on equity10.7%-37.8pp

Debt / equity0.1×0.0×

Current ratio4.4×0.0×

Where this comes from

Reported directly by Edwards Lifesciences in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Edwards Lifesciences's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Edwards Lifesciences's D&A?: Edwards Lifesciences (EW) reported D&A of $40.9M in Q1 2026.
How has Edwards Lifesciences's D&A changed year-over-year?: Edwards Lifesciences's D&A increased by 11.7% year-over-year, from $36.6M to $40.9M.
What is the long-term trend for Edwards Lifesciences's D&A?: Over 4 years (2021 to 2025), Edwards Lifesciences's D&A has grown at a 3.8% compound annual growth rate (CAGR), from $134.8M to $156.6M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.